Aravive Inc (NASDAQ:ARAV)

2.30
Delayed Data
As of Mar 24
 +0.03 / +1.32%
Today’s Change
0.58
Today|||52-Week Range
2.46
+74.24%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$116.1M

Company Description

Aravive, Inc. operates as a clinical stage biotechnology company, which engages in the development of transformative treatments designed to halt the progression of life threatening disease, including cancer and fibrosis. The company was founded on December 10, 2008 and is headquartered in Houston, TX.

Contact Information

Aravive, Inc.
River Oaks Tower
Houston Texas 77098
P:(936) 355-1910
Investor Relations:
(562) 373-5787

Employees

Shareholders

Individual stakeholders51.15%
Other institutional10.80%
Mutual fund holders1.49%

Top Executives

Gail Frances McIntyrePresident, Chief Executive Officer & Director
Leonard Scott DoveChief Operating Officer
Rudy C. HowardChief Financial & Accounting Officer
Robert B. GellerChief Medical Officer
Marek CiszewskiVice President-Investor Relations